Showing 34,879 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Hepatitis C treatment

Generic hepatitis C drugs purchased online achieve high cure rates

News
27 October 2016
Health monitoring in resource-limited settings

Africa has an essential medicines list. Now it needs one for diagnostics

Editor's pick
The Conversation
27 October 2016
Tuberculosis & HIV

South Africa’s healthcare workers hard hit by TB infections

Editor's pick
Health-e
27 October 2016
Global health initiatives

AIDS politics: Institutionalization of Solidarity, Exclusion of Context

Editor's pick
Sexuality Policy Watch
27 October 2016
Finance & funding

Generic HIV drugs will be a good thing right?

Editor's pick
Project Inform
27 October 2016
Sex workers

HIVR4P 2016: Services for female sex workers show low cost impact

Editor's pick
Science Speaks
27 October 2016
Drug-resistant TB

Final data backs early findings, WHO recommendations, showing shorter MDR TB treatment course working better

Editor's pick
Science Speaks
26 October 2016
History of HIV & AIDS

HIV Patient Zero cleared by science

Editor's pick
BBC Health
26 October 2016
TB treatment

47th Union World Conference on Lung Health: Even “free” TB treatment can come with catastrophic costs

Editor's pick
Science Speaks
26 October 2016
History of HIV & AIDS

At gathering of HIV/AIDS pioneers, raw memories mix with current conflicts

Editor's pick
Science Magazine
26 October 2016
PrEP science

Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

News
26 October 2016
Transgender people

This Isn't Just Research, It's Our Lives: Centering Trans Stories In HIV Treatment & Prevention

Editor's pick
AIDS United
26 October 2016
Harm reduction

Researchers find people who inject drugs would be willing to switch to safer equipment

Editor's pick
National Institute for Health Research
26 October 2016
PrEP

Two Thirds of Oral PrEP-Using MSM Would Switch to Long-Term Shots

Editor's pick
NATAP
26 October 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
Tuberculosis & HIV

2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time To Lose

Editor's pick
Treatment Action Group
26 October 2016
Drug-resistant TB

Access: MSF reports on use of the new tuberculosis drugs bedaquiline and delamanid

Editor's pick
Médecins Sans Frontières (MSF) International
26 October 2016
Weight gain & lipodystrophy

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

News
26 October 2016
Ageing & HIV

French study reveals the growing complexity of medical needs as people with HIV age

News
25 October 2016
Sexually transmitted infections epidemiology

STD rates sharply rise in U.S. says CDC – Will misinformation from PrEP critics prevail?

Editor's pick
Project Inform
25 October 2016
Side effects

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

News
25 October 2016
PrEP programmes & uptake

Some of the Americans who need PrEP the most face the greatest barriers to getting it

News
25 October 2016
Circumcision

HIVR4P 2016: Circumcision offers major contribution to ending HIV epidemic as a public health threat

Editor's pick
Science Speaks
25 October 2016
Changing treatment

Two-drug HIV therapy just as effective as three-drug therapy

News
25 October 2016